CHA Biotech Co. Ltd (085660) - Total Liabilities

Latest as of March 2026: ₩1.77 Trillion KRW ≈ $1.20 Billion USD

Based on the latest financial reports, CHA Biotech Co. Ltd (085660) has total liabilities worth ₩1.77 Trillion KRW (≈ $1.20 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

CHA Biotech Co. Ltd - Total Liabilities Trend (2008–2025)

This chart illustrates how CHA Biotech Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is CHA Biotech Co. Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

CHA Biotech Co. Ltd Competitors by Total Liabilities

The table below lists competitors of CHA Biotech Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Personalis Inc NASDAQ:PSNL	USA	$70.63 Million
Hypoport SE XETRA:HYQ	Germany	€308.32 Million
Konka Group Co Ltd SHE:000016	China	CN¥25.60 Billion
Xingtong Shipping Co. Ltd. SHG:603209	China	CN¥2.19 Billion
JNTC Co. Ltd KQ:204270	Korea	₩300.47 Billion
Actron Technology TWO:8255	Taiwan	NT$5.77 Billion
Pony Testing International Group Co SHE:300887	China	CN¥513.12 Million

Liability Composition Analysis (2008–2025)

This chart breaks down CHA Biotech Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 085660 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.43	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.63	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CHA Biotech Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CHA Biotech Co. Ltd (2008–2025)

The table below shows the annual total liabilities of CHA Biotech Co. Ltd from 2008 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩1.74 Trillion ≈ $1.18 Billion	-8.97%
2024-12-31	₩1.91 Trillion ≈ $1.29 Billion	+78.60%
2023-12-31	₩1.07 Trillion ≈ $724.61 Million	-18.71%
2022-12-31	₩1.32 Trillion ≈ $891.34 Million	+21.89%
2021-12-31	₩1.08 Trillion ≈ $731.27 Million	+12.57%
2020-12-31	₩958.62 Billion ≈ $649.64 Million	+22.00%
2019-12-31	₩785.74 Billion ≈ $532.48 Million	+26.62%
2018-12-31	₩620.54 Billion ≈ $420.53 Million	+10.25%
2017-12-31	₩562.87 Billion ≈ $381.45 Million	+16.63%
2016-12-31	₩482.61 Billion ≈ $327.06 Million	+36.05%
2015-12-31	₩354.73 Billion ≈ $240.39 Million	+93.39%
2014-12-31	₩183.43 Billion ≈ $124.31 Million	+5.96%
2013-12-31	₩173.12 Billion ≈ $117.32 Million	-7.45%
2012-12-31	₩187.06 Billion ≈ $126.76 Million	-1.32%
2011-12-31	₩189.56 Billion ≈ $128.46 Million	+7.67%
2010-12-31	₩176.06 Billion ≈ $119.32 Million	+71.36%
2009-12-31	₩102.75 Billion ≈ $69.63 Million	+402.00%
2008-12-31	₩20.47 Billion ≈ $13.87 Million	--

About CHA Biotech Co. Ltd

KQ:085660 Korea Biotechnology

Market Cap

$625.66 Million

₩923.23 Billion KRW

Market Cap Rank

#11267 Global

#307 in Korea

Share Price

₩12080.00

Change (1 day)

-3.97%

52-Week Range

₩10120.00 - ₩23850.00

All Time High

₩40950.00